Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Foghorn Therapeutics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −6 vs. Q1 2021
- Shares held
- 23.9M
- +588.7K (+2.5%) vs. Q1 2021
- Total value
- $255.1M
- −$51.5M (−16.8%) vs. Q1 2021
- New holders
- 3
- 20 more added
- Sold out
- 9
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FHTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $219.2M |
| Q1 2026 | 105 | $212.4M |
| Q4 2025 | 93 | $226.1M |
| Q3 2025 | 88 | $200.3M |
| Q2 2025 | 82 | $192.5M |
| Q1 2025 | 90 | $147.5M |
| Q4 2024 | 87 | $191.4M |
| Q3 2024 | 79 | $375.5M |
| Q2 2024 | 72 | $228.8M |
| Q1 2024 | 69 | $180.7M |
| Q4 2023 | 59 | $171.8M |
| Q3 2023 | 61 | $143.8M |
| Q2 2023 | 59 | $188.4M |
| Q1 2023 | 61 | $181.5M |
| Q4 2022 | 65 | $166.5M |
| Q3 2022 | 62 | $225.7M |
| Q2 2022 | 60 | $357.4M |
| Q1 2022 | 61 | $379.1M |
| Q4 2021 | 60 | $553.5M |
| Q3 2021 | 47 | $338.2M |
| Q2 2021 | 39 | $255.1M |
| Q1 2021 | 45 | $306.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Foghorn Therapeutics Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $135.2M | 1.73% | 00.0% | Unchanged |
| FMR LLC | 2,540,434 | $27.1M | 0.00% | −32,600−1.3% | Reduced |
| Artal Group S.A. | 1,720,720 | $18.4M | 0.42% | 00.0% | Unchanged |
| Euclidean Capital LLC | 1,261,261 | $13.5M | 4.37% | 00.0% | Unchanged |
| BlackRock Inc. | 1,093,860 | $11.7M | 0.00% | +661,735+153.1% | Added |
| Morgan Stanley | 980,209 | $10.5M | 0.00% | +586,487+149.0% | Added |
| Vanguard Group Inc | 683,778 | $7.30M | 0.00% | +276,444+67.9% | Added |
| Monashee Investment Management LLC | 530,581 | $5.66M | 0.68% | 00.0% | Unchanged |
| Alphabet Inc. | 500,901 | $5.34M | 0.11% | 00.0% | Unchanged |
| Birchview Capital, LP | 314,143 | $3.35M | 2.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 237,744 | $2.54M | 0.00% | +91,104+62.1% | Added |
| Casdin Capital, LLC | 216,216 | $2.31M | 0.06% | 00.0% | Unchanged |
| Millennium Management LLC | 195,762 | $2.09M | 0.00% | +33,644+20.8% | Added |
| State Street Corp | 189,399 | $2.02M | 0.00% | +80,300+73.6% | Added |
| Deutsche Bank AG | 189,109 | $2.02M | 0.00% | −33,805−15.2% | Reduced |
| Northern Trust Corp | 162,900 | $1.74M | 0.00% | +78,604+93.2% | Added |
| Suvretta Capital Management, LLC | 84,000 | $896.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 71,361 | $762.0K | 0.00% | +23,758+49.9% | Added |
| Nuveen Asset Management, LLC | 56,410 | $602.0K | 0.00% | +44,603+377.8% | Added |
| Bank of New York Mellon Corp | 51,419 | $549.0K | 0.00% | +31,979+164.5% | Added |
| California State Teachers Retirement System | 26,977 | $288.0K | 0.00% | +16,099+148.0% | Added |
| JPMorgan Chase & Co | 26,235 | $280.0K | 0.00% | +6,224+31.1% | Added |
| HSBC Holdings PLC | 20,792 | $219.0K | 0.00% | +2,050+10.9% | Added |
| New York State Common Retirement Fund | 16,758 | $179.0K | 0.00% | +12,658+308.7% | Added |
| Rhumbline Advisers | 15,659 | $167.0K | 0.00% | +15,659 | New |
| Bank of America Corp | 12,270 | $131.0K | 0.00% | +6,861+126.8% | Added |
| American International Group, Inc. | 10,960 | $117.0K | 0.00% | +6,768+161.5% | Added |
| Fiduciary Trust Co | 10,879 | $116.0K | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 5,000 | $53.0K | 0.01% | +5,000 | New |
| Royal Bank of Canada | 2,588 | $27.0K | 0.00% | +1,309+102.3% | Added |
| Legal & General Group Plc | 1,722 | $18.0K | 0.00% | +1,006+140.5% | Added |
| Ameritas Investment Partners, Inc. | 1,534 | $16.0K | 0.00% | +932+154.8% | Added |
| Tower Research Capital LLC (TRC) | 1,399 | $15.0K | 0.00% | −568−28.9% | Reduced |
| Citigroup Inc | 930 | $10.0K | 0.00% | +453+95.0% | Added |
| Capital Analysts, LLC | 605 | $6.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 140 | $1.49K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 76 | $1.00K | 0.00% | +76 | New |
| Wells Fargo & Company | 38 | $0 | 0.00% | −2,213−98.3% | Reduced |
| Retirement Group, LLC | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −109,200−100.0% | Sold out |
| Pictet Asset Management Ltd | 0 | $0 | 0.00% | −98,085−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −69,132−100.0% | Sold out |
| Board of Trustees of The Leland Stanford Junior University | 0 | $0 | 0.00% | −30,657−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −16,190−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,136−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −280−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −222−100.0% | Sold out |